2,3-Dichloro-5-(difluoromethyl)pyridine, 97%, 250mg

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-bis((tert-butyldimethylsilyl)oxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95%, 2g

Methyl 4-hydroxy-2-methylbenzoate, 98.00%, 10g

(R,R,R)-(+)-Tol-SKP, 95%, 100mg

4,5,6,7-Tetrahydro-1H-pyrazolo[3,4-c]pyridine hydrochloride, 97%, 100mg

N~3~-methyl-beta-alaninamide hydrochloride, 95.0%, 1g

Pimobendan>98.0%(T)(HPLC)250mg

3-(2-Fluorophenyl)propionic acid, 98.0%, 1g

4-Bromo-2-fluoro-5-iodopyridine, 97%, 1g

((Benzyloxy)carbonyl)-L-alanyl-L-valine, 97%, 1g

Sofosbuvir impurity E, 1mg

2-Chloro-6-hydroxybenzoic acid, 95.0%, 250mg

(S)-3-Boc-Amino-g-butyrolactone, 95.0%, 5g